Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CDKL5 regulates p62-mediated selective autophagy and confers protection against neurotropic viruses
Josephine W. Thinwa, Zhongju Zou, Emily Parks, Salwa Sebti, Kelvin Hui, Yongjie Wei, Mohammad Goodarzi, Vibha Singh, Greg Urquhart, Jenna L. Jewell, Julie K. Pfeiffer, Beth Levine, Tiffany A. Reese, Michael U. Shiloh
Josephine W. Thinwa, Zhongju Zou, Emily Parks, Salwa Sebti, Kelvin Hui, Yongjie Wei, Mohammad Goodarzi, Vibha Singh, Greg Urquhart, Jenna L. Jewell, Julie K. Pfeiffer, Beth Levine, Tiffany A. Reese, Michael U. Shiloh
View: Text | PDF
Research Article Infectious disease Virology

CDKL5 regulates p62-mediated selective autophagy and confers protection against neurotropic viruses

  • Text
  • PDF
Abstract

Virophagy, the selective autophagosomal engulfment and lysosomal degradation of viral components, is crucial for neuronal cell survival and antiviral immunity. However, the mechanisms leading to viral antigen recognition and capture by autophagic machinery remain poorly understood. Here, we identified cyclin-dependent kinase–like 5 (CDKL5), known to function in neurodevelopment, as an essential regulator of virophagy. Loss-of-function mutations in CDKL5 are associated with a severe neurodevelopmental encephalopathy. We found that deletion of CDKL5 or expression of a clinically relevant pathogenic mutant of CDKL5 reduced virophagy of Sindbis virus (SINV), a neurotropic RNA virus, and increased intracellular accumulation of SINV capsid protein aggregates and cellular cytotoxicity. Cdkl5-knockout mice displayed increased viral antigen accumulation and neuronal cell death after SINV infection and enhanced lethality after infection with several neurotropic viruses. Mechanistic studies demonstrated that CDKL5 directly binds the canonical selective autophagy receptor p62 and phosphorylates p62 at T269/S272 to promote its interaction with viral capsid aggregates. We found that CDKL5-mediated phosphorylation of p62 facilitated the formation of large p62 inclusion bodies that captured viral capsids to initiate capsid targeting to autophagic machinery. Overall, these findings identify a cell-autonomous innate immune mechanism for autophagy activation to clear intracellular toxic viral protein aggregates during infection.

Authors

Josephine W. Thinwa, Zhongju Zou, Emily Parks, Salwa Sebti, Kelvin Hui, Yongjie Wei, Mohammad Goodarzi, Vibha Singh, Greg Urquhart, Jenna L. Jewell, Julie K. Pfeiffer, Beth Levine, Tiffany A. Reese, Michael U. Shiloh

×

Figure 7

CDKL5 phosphorylates p62 at Thr269/Ser272 to impact binding of p62 to capsid.

Options: View larger image (or click on image) Download as PowerPoint
CDKL5 phosphorylates p62 at Thr269/Ser272 to impact binding of p62 to ca...
(A) In vitro kinase assay with recombinant CDKL5 (rCDKL5) and rp62 using [γ-32P]ATP for a 30-minute reaction. Top: 32P autoradiography of p62 and CDKL5 phosphorylation. Bottom: Coomassie Brilliant Blue gel staining. (B) In vitro kinase assay with p62 phosphorylation detected using anti-T269/S272 phosphospecific antibody. (C) In vitro kinase assay of affinity-purified EV, WT, and KD CDKL5–3×FLAG from HeLa cells and rp62 followed by p62 T269/S272 phosphorylation detection. Blot representative of 3 independent experiments. (D) WT and CDKL5-KO HeLa cells infected with SINV/HA-capsid (MOI = 10) were lysed directly in Laemmli buffer. Blot representative of 3 independent experiments. (E) Quantification of p-T269/S272 normalized to total p62. Bars are mean ± SEM. (F) Fractionation of SINV/HA-capsid–infected WT and CDKL5-KO HeLa cells into RIPA buffer–soluble and –insoluble fractions. Blot is representative of 3 independent experiments. (G–J) Immunofluorescence microscopy of WT and CDKL5-KO HeLa cells infected with WT SINV (MOI = 10, 8 hours). (G) Representative fluorescence micrographs. Analysis of (H) size, (I) count, and (J) ratio of p-T269/S272 p62 to total p62 bodies per cell with 50 cells per condition. Bars are mean ± SEM. Scale bar: 10 μm. (K and L) FLAG immunoprecipitation of SINV/HA-capsid virus–infected CDKL5-KO HeLa cells expressing EV, WT p62, alanine-substituted p62T269A/S272A, or phosphomimetic p62T269E/S272D-3×FLAG. (K) Representative blot. (L) Densitometry analysis of capsid coimmunoprecipitating with p62-FLAG normalized to FLAG. Bars are mean ± SEM of 3 experiments. P values were determined by 1-way ANOVA with Šidák’s multiple-comparison test (E and H–J) or 1-way ANOVA with Dunnett’s multiple-comparison test (L). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts